Developer of advanced therapeutics designed to address unmet needs in the management of late-stage chronic kidney diseases. The company creates upacicalcet, which is a novel calcimimetic with the pote...

Healthcare
Raleigh, NC, United States
Founded 2021
8 employees
Website
Valuation
$295M
Market implied
Share Price
N/A
Total Raised
$266M
Last Round
N/A

Get the full picture

Create a free account to unlock Pathalys Pharma's funding history, team members, investor details, and more.

15 free profiles/month · No credit card required